What does this research mean for the field?

Renal involvement in idiopathic multicentric Castleman disease-TAFRO syndrome is highly prevalent and frequently manifests as acute kidney injury linked to systemic inflammation, which is largely reversible with early aggressive therapy and supportive renal care. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Characterize the clinical and pathological features of kidney involvement and evaluate patient outcomes in idiopathic multicentric Castleman disease-TAFRO syndrome.

September 15, 2026Clinical Kidney JournalOpen Access

Kidney involvement in idiopathic multicentric castleman disease-TAFRO syndrome: clinical spectrum, pathology, and outcomes

View Full Paper

Ask AI

Bookmark

Authors

SZShuo Zhang HLHanshu Liu SLSiyuan Li

Discussion

Member takes

Overview

Retrospective cohort study finds frequent acute kidney injury and high recovery rates in iMCD-TAFRO syndrome, suggesting that aggressive anti-inflammatory and supportive care improves prognosis.

Key Points

Characterize the clinical and pathological features of kidney involvement and evaluate patient outcomes in idiopathic multicentric Castleman disease-TAFRO syndrome.
Conducted a 10-year retrospective cohort study of 48 patients (70.8% male, mean age 45 ± 15 years) diagnosed with iMCD-TAFRO at Peking Union Medical College Hospital.
Identified renal involvement using iMCD consensus criteria, reviewed renal biopsies (n = 7), and evaluated survival using Kaplan-Meier analysis.
Renal involvement occurred in 95.8% (46/48) of patients, with acute kidney injury developing in 80.4% (37/46) and requiring renal replacement therapy in 37.8% of AKI cases.
Renal biopsies revealed glomerular microangiopathy in 6 of 7 cases, with AKI correlating with elevated C-reactive protein and D-dimer levels.
Full renal function recovery was achieved in 75.7% (28/37) of AKI patients, with no significant difference in overall survival between dialyzed and non-dialyzed patients.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/6aa9134b9013453be30a1185 https://doi.org/10.1093/ckj/sfag326

View Full Paper

Ask AI

Bookmark

September 15, 2026Clinical Kidney JournalOpen Access

Kidney involvement in idiopathic multicentric castleman disease-TAFRO syndrome: clinical spectrum, pathology, and outcomes

View Full Paper

Ask AI

Bookmark

Authors

SZShuo Zhang HLHanshu Liu SLSiyuan Li

Discussion

Member takes

Overview

Retrospective cohort study finds frequent acute kidney injury and high recovery rates in iMCD-TAFRO syndrome, suggesting that aggressive anti-inflammatory and supportive care improves prognosis.

Key Points

Characterize the clinical and pathological features of kidney involvement and evaluate patient outcomes in idiopathic multicentric Castleman disease-TAFRO syndrome.
Conducted a 10-year retrospective cohort study of 48 patients (70.8% male, mean age 45 ± 15 years) diagnosed with iMCD-TAFRO at Peking Union Medical College Hospital.
Identified renal involvement using iMCD consensus criteria, reviewed renal biopsies (n = 7), and evaluated survival using Kaplan-Meier analysis.
Renal involvement occurred in 95.8% (46/48) of patients, with acute kidney injury developing in 80.4% (37/46) and requiring renal replacement therapy in 37.8% of AKI cases.
Renal biopsies revealed glomerular microangiopathy in 6 of 7 cases, with AKI correlating with elevated C-reactive protein and D-dimer levels.
Full renal function recovery was achieved in 75.7% (28/37) of AKI patients, with no significant difference in overall survival between dialyzed and non-dialyzed patients.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/6aa9134b9013453be30a1185 https://doi.org/10.1093/ckj/sfag326

View Full Paper

Ask AI

Bookmark